XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Xing, Zhaoquan ^a   Zhou, Zunlin ^a   Yu, Rong ^b,c   Li, Shuling ^a   Li, Chunde ^c   Nilsson, Sten ^c   Liu, Zhaoxu ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; MESSENGER RNA; OCTREOTIDE; PROTEIN; SOMATOSTATIN; UNCLASSIFIED DRUG; XAF1 PROTEIN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; SIGNAL PEPTIDE; TUMOR PROTEIN; XAF1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; GENE EXPRESSION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, HORMONAL; BLOTTING, WESTERN; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEOPLASM PROTEINS; OCTREOTIDE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOMATOSTATIN;

EID: 78649947887     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-162     Document Type: Article

References (39)

1. Cancer statistics, 2008. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun, CA Cancer J Clin 2008 58 71 96 10.3322/CA.2007.0010 18287387
2. Cancer incidence and mortality in Europe, 2004. P Boyle J Ferlay, Ann Oncol 2005 16 481 488 10.1093/annonc/mdi098 15718248
3. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. M Quinn P Babb, BJU Int 2002 90 162 173 10.1046/j.1464-410X.2002.2822.x 12081758 (Pubitemid 34779587)
4. Genetics of prostate cancer: too many loci, too few genes. EA Ostrander JL Stanford, Am J Hum Gnent 2000 67 1367 1375 10.1086/316916
5. Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease. R Foley D Hollywood M Lawler, Endocr Relat Cancer 2004 11 477 488 10.1677/erc.1.00699 15369449
6. Apoptosis in prostate cancer: progressive and therapeutic implications (Review). G Wang E Reed QQ Li, Int J Mol Med 2004 14 23 34 15202013
7. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention. L Zeng N Kyprianou, Prostate Cancer Prostatic Dis 2005 8 7 13 10.1038/sj.pcan.4500757 15477876
8. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. P Liston WG Fong NL Kelly S Toji T Miyazaki D Conte K Tamai CG Craig MW McBurney RG Korneluk, Nat Cell Biol 2001 3 128 133 10.1038/35055027 11175744
9. Surface adsorption of DNA to tissue engineering scaffolds for efficient gene delivery. JH Jang Z Bengali TL Houchin LD Shea, J Biomed Mater Res 2006 77 50 58 10.1002/jbm.a.30643
10. Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis. DW Leaman M Chawla-Sarkar K Vyas M Reheman K Tamai S Toji EC Borden, J Biol Chem 2002 277 28504 28511 10.1074/jbc.M204851200 12029096
11. Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses. SK Chung MG Lee BK Ryu JH Lee J Han DS Byun KS Chae KY Lee JY Jang HJ Kim SG Chi, Gastroenterology 2007 132 2459 2477 10.1053/j.gastro.2007.04.024 17570219
12. Xaf1 can cooperate with TNFalpha in the induction of apoptosis, independently of interaction with XIAP. Y Xia R Novak J Lewis CS Duckett AC Phillips, Mol Cell Biochem 2006 286 67 76 10.1007/s11010-005-9094-2 16432762
13. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. WG Fong P Liston E Rajcan-Separovic M St Jean C Craig RG Korneluk, Genomics 2000 70 113 122 10.1006/geno.2000.6364 11087668
14. XAF1 expression is significantly reduced in human melanoma. KC Ng EI Campos M Martinka G Li, J Invest Dermatol 2004 123 1127 1134 10.1111/j.0022-202X.2004.23467.x 15610524 (Pubitemid 39586836)
15. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses. MG Lee JS Huh SK Chung JH Lee DS Byun BK Ryu MJ Kang KS Chae SJ Lee CH Lee JI Kim SG Chang SG Chi, Oncogene 2006 25 5807 5822 10.1038/sj.onc.1209867 16909101
16. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. DS Byun K Cho BK Ryu MG Lee MJ Kang HR Kim SG Chi, Cancer Res 2003 63 7068 7075 14612497
17. Phase I trial on sms-D70 somatostatin analogue in advanced prostate and renal cell cancer. TK Joensuu S Nilsson AR Holmberg M Marquez M Tenhunen T Saarto H Joensuu, Ann N Y Acad Sci 2004 1028 361 374 10.1196/annals.1322.042 15650261
18. Radiolabelled somatostatin analog therapy in prostate cancer: current status and future directions. Y Liu, Cancer Lett 2006 239 21 26 10.1016/j.canlet.2005.07.020 16126334
19. Somatostatin receptors. LN Moller CE Stidsen B Hartmann JJ Holst, Biochim Biophys Acta 2003 1616 1 84 10.1016/S0005-2736(03)00235-9 14507421
20. Regulation and function of somatostatin receptors. G Olias C Viollet H Kusserow J Epelbaum W Meyerhof, J Neurochem 2004 89 1057 1091 10.1111/j.1471-4159.2004.02402.x 15147500
21. Somatostatin receptors in prostate tissues and derived cell cultures, and the in vitro growth inhibitory effect of BIM-23014 analog. R Tatoud A Degeorges G Prevost JL Hoepffner C Gauville G Millot F Thomas F Calvo, Mol Cell Endocrinol 1995 113 195 204 10.1016/0303-7207(95)03630-P 8674827
22. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. LK Kvols CG Moertel MJ O'Connell AJ Schutt J Rubin RG Hahn, N Engl J Med 1986 315 663 666 10.1056/NEJM198609113151102 2427948
23. Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin. Z Liu M Marquez S Nilsson AR Holmberg, Oncol Rep 2009 22 1451 1458 19885599
24. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. Z Liu M Marquez S Nilsson AR Holmberg, Oncol Rep 2008 20 151 154 18575731
25. Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: possible mechanism of action. TA Brevini R Bianchi M Motta, J Clin Endocrinol Metab 1993 77 626 631 10.1210/jc.77.3.626 7690358
26. XAF1 mediates tumor necrosis factor-alpha-induced apoptosis and X-linked inhibitor of apoptosis cleavage by acting through the mitochondrial pathway. SL Straszewski-Chavez IP Visintin N Karassina G Los P Liston R Halaban A Fadiel G Mor, J Biol Chem 2007 282 13059 13072 10.1074/jbc.M609038200 17329253
27. Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-beta. OC Micali HH Cheung S Plenchette SL Hurley P Liston EC LaCasse RG Korneluk, BMC Cancer 2007 7 52 10.1186/1471-2407-7-52 17376236
28. Regulation of XAF1 expression in human colon cancer cell by interferon beta: activation by the transcription regulator STAT1. Y Sun L Qiao HH Xia MC Lin B Zou Y Yuan S Zhu Q Gu TK Cheung HF Kung MF Yuen AO Chan BC Wong, Cancer Lett 2008 260 62 71 10.1016/j.canlet.2007.10.014 18035482
29. XAF1 mediates apoptosis through an extracellular signal-regulated kinase pathway in colon cancer. LF Yu J Wang B Zou MC Lin YL Wu HH Xia YW Sun Q Gu H He SK Lam HF Kung BC Wong, Cancer 2007 109 1996 2003 10.1002/cncr.22624 17385215
30. Restoration of XAF1 expression induces apoptosis and inhibits tumor growth in gastric cancer. SP Tu P Liston JT Cui MC Lin XH Jiang Y Yang Q Gu SH Jiang CT Lum HF Kung RG Korneluk BC Wong, Int J Cancer 2009 125 688 697 10.1002/ijc.24282 19358264
31. Low expression of XIAP-associated factor 1 in human colorectal cancers. TL Ma PH Ni J Zhong JH Tan MM Qiao SH Jiang, Chin J Dig Dis 2005 6 10 14 10.1111/j.1443-9573.2005.00180.x 15667552
32. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients. CG Ferreira P van der Valk SW Span I Ludwig EF Smit FA Kruyt HM Pinedo H van Tinteren G Giaccone, Clin Cancer Res 2001 7 2468 2474 11489828
33. The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia. P Secchiero MG di lasio E Melloni R Vlotan C Celeghini M Tiribelli M Dal Bo V Gattei G Zauli, Leukemia 2010 24 480 483 10.1038/leu.2009.215 19847196
34. Caspase-8-mediated intracellular acidification precedes mitochondrial dysfunction in somatostatin-induced apoptosis. D Liu G Martino M Thangaraju M Sharma F Halwani SH Shen YC Patel CB Srikant, J Biol Chem 2000 275 9244 9250 10.1074/jbc.275.13.9244 10734062
35. Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells. K Sharma CB Srikant, Int J Cancer 1998 76 259 266 10.1002/(SICI)1097-0215(19980413)76: 2<259::AID-IJC14>3.0.CO;2-7 9537589
36. AIDS-related Kaposi's sarcoma with chylothorax and pericardial involvement satisfactorily treated with liposomal doxorubicin. JA Maradona JA Carton V Asensi A Rodriguez-Guardado, AIDS (London, England) 2002 16 806 11964546
37. Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis. J Guillermet N Saint-Laurent P Rochaix O Cuvillier T Levade AV Schally L Pradayrol L Buscail C Susini C Bousquet, Proc Natl Acad Sci USA 2003 100 155 160 10.1073/pnas.0136771100 12490654
38. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. JC Reubi JC Schar B Waser S Wenger A Heppeler JS Schmitt HR Macke, Eur J Nucl Med 2000 27 273 282 10.1007/s002590050034 10774879
39. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. JC Reubi B Waser JC Schaer JA Laissue, Eur J Nucl Med 2001 28 836 846 10.1007/s002590100541 11504080